Logo image of ELVA.CA

ELECTROVAYA INC (ELVA.CA) Stock Fundamental Analysis

TSX:ELVA - Toronto Stock Exchange - CA28617B6061 - Common Stock - Currency: CAD

6.45  +0.05 (+0.78%)

Fundamental Rating

5

ELVA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 15 industry peers in the Electrical Equipment industry. ELVA has an average financial health and profitability rating. ELVA is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ELVA has reported negative net income.
In the past year ELVA has reported a negative cash flow from operations.
In the past 5 years ELVA reported 4 times negative net income.
ELVA had negative operating cash flow in 4 of the past 5 years.
ELVA.CA Yearly Net Income VS EBIT VS OCF VS FCFELVA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

ELVA has a Return On Assets of -0.07%. This is amongst the best in the industry. ELVA outperforms 86.67% of its industry peers.
Looking at the Return On Equity, with a value of -0.14%, ELVA belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
ELVA has a Return On Invested Capital of 2.02%. This is amongst the best in the industry. ELVA outperforms 86.67% of its industry peers.
Industry RankSector Rank
ROA -0.07%
ROE -0.14%
ROIC 2.02%
ROA(3y)-14.68%
ROA(5y)-16.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ELVA.CA Yearly ROA, ROE, ROICELVA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

ELVA has a Operating Margin of 2.12%. This is amongst the best in the industry. ELVA outperforms 86.67% of its industry peers.
ELVA has a better Gross Margin (30.23%) than 80.00% of its industry peers.
In the last couple of years the Gross Margin of ELVA has declined.
Industry RankSector Rank
OM 2.12%
PM (TTM) N/A
GM 30.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5Y-5.01%
ELVA.CA Yearly Profit, Operating, Gross MarginsELVA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

4

2. Health

2.1 Basic Checks

ELVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ELVA has more shares outstanding than it did 1 year ago.
ELVA has more shares outstanding than it did 5 years ago.
ELVA has a worse debt/assets ratio than last year.
ELVA.CA Yearly Shares OutstandingELVA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ELVA.CA Yearly Total Debt VS Total AssetsELVA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ELVA has an Altman-Z score of 2.61. This is not the best score and indicates that ELVA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.61, ELVA perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that ELVA is somewhat dependend on debt financing.
ELVA has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: ELVA underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 2.61
ROIC/WACC0.14
WACC14.42%
ELVA.CA Yearly LT Debt VS Equity VS FCFELVA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

ELVA has a Current Ratio of 3.89. This indicates that ELVA is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.89, ELVA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
ELVA has a Quick Ratio of 3.01. This indicates that ELVA is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.01, ELVA is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 3.01
ELVA.CA Yearly Current Assets VS Current LiabilitesELVA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.50% over the past year.
Looking at the last year, ELVA shows a decrease in Revenue. The Revenue has decreased by -1.21% in the last year.
The Revenue has been growing by 55.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y56.77%
Revenue growth 5Y55.61%
Sales Q2Q%40.42%

3.2 Future

The Earnings Per Share is expected to grow by 98.17% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 38.69% on average over the next years. This is a very strong growth
EPS Next Y516.5%
EPS Next 2Y299.25%
EPS Next 3Y156.93%
EPS Next 5Y98.17%
Revenue Next Year42.39%
Revenue Next 2Y47.07%
Revenue Next 3Y44.44%
Revenue Next 5Y38.69%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ELVA.CA Yearly Revenue VS EstimatesELVA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
ELVA.CA Yearly EPS VS EstimatesELVA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 -1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Forward Earnings ratio of 11.21 indicates a reasonable valuation of ELVA.
Based on the Price/Forward Earnings ratio, ELVA is valued a bit cheaper than 80.00% of the companies in the same industry.
ELVA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.28.
Industry RankSector Rank
PE N/A
Fwd PE 11.21
ELVA.CA Price Earnings VS Forward Price EarningsELVA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

86.67% of the companies in the same industry are more expensive than ELVA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 88.2
ELVA.CA Per share dataELVA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

ELVA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELVA's earnings are expected to grow with 156.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y299.25%
EPS Next 3Y156.93%

0

5. Dividend

5.1 Amount

ELVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ELECTROVAYA INC

TSX:ELVA (8/7/2025, 7:00:00 PM)

6.45

+0.05 (+0.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-13 2025-08-13/amc
Inst Owners12.96%
Inst Owner ChangeN/A
Ins Owners34.08%
Ins Owner ChangeN/A
Market Cap258.71M
Analysts82
Price Target6.13 (-4.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.57%
Min EPS beat(2)-28.7%
Max EPS beat(2)21.57%
EPS beat(4)2
Avg EPS beat(4)-6.68%
Min EPS beat(4)-119.61%
Max EPS beat(4)100%
EPS beat(8)5
Avg EPS beat(8)24.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.7%
Min Revenue beat(2)-9.7%
Max Revenue beat(2)-7.69%
Revenue beat(4)0
Avg Revenue beat(4)-17.07%
Min Revenue beat(4)-45.33%
Max Revenue beat(4)-5.56%
Revenue beat(8)1
Avg Revenue beat(8)-13.2%
Revenue beat(12)1
Avg Revenue beat(12)-15.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-42.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.76%
Revenue NY rev (1m)-5.54%
Revenue NY rev (3m)-5.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.21
P/S 3.92
P/FCF N/A
P/OCF N/A
P/B 8.9
P/tB 8.9
EV/EBITDA 88.2
EPS(TTM)0
EYN/A
EPS(NY)0.58
Fwd EY8.92%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.65
BVpS0.72
TBVpS0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.14%
ROCE 2.8%
ROIC 2.02%
ROICexc 2.03%
ROICexgc 2.03%
OM 2.12%
PM (TTM) N/A
GM 30.23%
FCFM N/A
ROA(3y)-14.68%
ROA(5y)-16.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5Y-5.01%
F-Score3
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA 6.42
Cap/Depr 72.78%
Cap/Sales 1.92%
Interest Coverage 0.42
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.89
Quick Ratio 3.01
Altman-Z 2.61
F-Score3
WACC14.42%
ROIC/WACC0.14
Cap/Depr(3y)26.17%
Cap/Depr(5y)54.51%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y516.5%
EPS Next 2Y299.25%
EPS Next 3Y156.93%
EPS Next 5Y98.17%
Revenue 1Y (TTM)-1.21%
Revenue growth 3Y56.77%
Revenue growth 5Y55.61%
Sales Q2Q%40.42%
Revenue Next Year42.39%
Revenue Next 2Y47.07%
Revenue Next 3Y44.44%
Revenue Next 5Y38.69%
EBIT growth 1Y-68.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year207.85%
EBIT Next 3Y117.24%
EBIT Next 5YN/A
FCF growth 1Y58.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.6%
OCF growth 3YN/A
OCF growth 5YN/A